Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH ANDREA MIYAHIRA
The Prostate Cancer Foundation: A Discussion with Andrea Miyahira

VIEW ALL PCF VIDEOS

Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH KENNETH PIENTA
The Process of Metastasis in Prostate Cancer

VIEW ALL PCF VIDEOS

European Society for Medical Oncology 2018 Congress

European Society for Medical Oncology 2018 Congress

INTERVIEW WITH FRED SAAD
A Renewed Analysis of ERA 223

VIEW ALL ESMO VIDEOS

Videos
State-of-the-industry video lectures by leading urology experts
Latest Videos
Featured Videos

ORLANDO, FL USA (UroToday.com) - Calcium phosphate stones are more common in basic urine pH. Thus, there is concern that the potassium citrate (KCIT) may increase the formation of this subtype of renal stones. As a result, Sara L Best and colleagues wanted to evaluate stone composition and 24-h urinary parameters in patients on KCIT.

The authors assessed patients who were given KCIT, retrospectively. The authors identified patients with 24hour urine analysis within 9 months of KCIT treatment initiation. They then compared pre- and post-KCIT variables including urine pH and assessing stone composition.

auaThe study included 80 patients in this retrospective review. Mean brushite composition of obese patients decreased after treatment but increased in non-obese patients. Calcium oxalate stone compositions, urinary citrate, and magnesium behaved similarly.

The authors concluded from their study that urine pH did not increase with KCIT treatment. BMI had an effect on the stone composition of patients. It seems that being obese may have an effect on stone formation due to potassium citrate treatment. However, the study may not have enough power for this analysis, and it would be beneficial to study this effect in a prospective clinical trial. The authors discussed limitations with the study, some of which included small sample size, retrospective design, and patient adherence to the medication. If the patients in the non-obese group were less compliant with KCIT, the results may have been different than presented. For future studies, this is an important consideration in designing a protocol.

Presented by Sara L. Best, MD at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

Madison, WI USA

Written by Garen Abedi, MD, University of California (Irvine), and medical writer for UroToday.com

 

@UroToday
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe

Calendar
Upcoming educational events
January 24-27, 2019 / The Westin Riverfront at Beaver Creek
29th Annual International Prostate Cancer Update (IPCU)
February 1, 2019 / Thomas Jefferson University, Jefferson Alumni Hall, 1020 Locust Street, Philadelphia, PA
2nd Annual Jefferson Urology Symposium: Emerging Technologies for the Treatment of BPH